Clinical Trial Update: Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting results for the irbesartan/hydrochlorothiazide combination in achieving target blood pressure for adults with moderate to severe …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• AVALIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED